inHEART
About inHEART
inHEART is a deep-tech healthcare AI company committed to delivering the world’s most sophisticated, AI-enabled digital twin of the heart to advance the care of patients living with cardiac disease. Their platform transforms preoperative medical images, such as cardiac CT and MRI scans, into highly detailed, interactive 3D models of the patient’s unique cardiac anatomy. These models provide unprecedented anatomical insights, including principal and collateral structures, and myocardial tissue characteristics like scar tissue and wall thinning, which are often unavailable through conventional imaging methods.
For physicians, this technology enables optimized treatment strategies and detailed pre-procedural planning, particularly for complex cardiac ablation procedures for arrhythmias like ventricular tachycardia. The digital twin assists in navigating instruments and can significantly reduce procedure duration and improve clinical outcomes by allowing clinicians to pinpoint arrhythmogenic areas with greater precision. The inHEART solution is commercially available in the US and EU and seamlessly integrates with major electroanatomic mapping (EAM) systems. Beyond therapeutic support, inHEART is actively developing AI-driven predictive models for early screening and detection of conditions such as heart failure, sudden cardiac death, and cardio-embolic stroke, aiming to shift healthcare from a reactive to a proactive paradigm in cardiac care.
Focus Areas
Business Intelligence
| Key Investors | Vesalius Biocapital IV, Elaia Partners, SWEN Capital Partners, Astorg, Cenitz, Cleverage Venture Capital, Sagana, NACO, Sofia Angel Ventures, CWR Funds, Webit Investment Network, Aquitaine Science Transfert, 50 Partners, Breega, FJ Labs |
| Partnerships | Dassault Systèmes, Philips Cardiologs, Incepto, CHU de Bordeaux, IHU Liryc, Circle Cardiovascular Imaging |
| Technology | AI-driven digital twin of the heart, cloud-based AI, proprietary segmentation algorithms, 3D cardiac models from CT and MR images, seamless integration with electroanatomic mapping (EAM) systems |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, inHEART offers a transformative approach to cardiac arrhythmia management. Their AI-driven digital twin technology provides unparalleled anatomical insights and detailed scar characterization from pre-procedural CT/MR images, enabling highly personalized and optimized treatment strategies before entering the lab. This leads to significantly reduced VT procedure times (up to 60%) and improved success rates, with a reported 38% reduction in VT recurrence. The seamless integration with existing EAM systems ensures a smooth workflow. Furthermore, inHEART's focus on predictive models for conditions like Sudden Cardiac Death and Cardio-embolic Stroke supports a shift towards proactive, rather than reactive, patient care, ultimately enhancing clinical decision-making and patient outcomes, especially in complex cases.
inHEART's solution is designed for seamless integration with all major electroanatomic mapping (EAM) systems, including Cartou00ae, Rhythmiau2122, Ensiteu2122, and Afferau2122. This ensures compatibility with existing cath lab infrastructure, facilitating adoption and enhancing intraprocedural guidance without requiring a complete overhaul of current equipment.
What the Web Says
inHEART is a company that develops AI-enabled digital twin technology for cardiac care, specifically focusing on 3D cardiac modeling for ventricular tachycardia (VT) ablations. The technology aims to provide unprecedented anatomical details, personalize treatment strategies, and improve clinical outcomes. While direct user reviews on platforms like G2, Glassdoor, and Capterra for inHEART as a product or employer are limited, testimonials from medical professionals highlight its positive impact on simplifying and accelerating procedures, and enhancing treatment strategies. The company is recognized for its proprietary software and ongoing research in cardiac imaging and digital technology.
Overall: PositiveStrengths
- Provides unprecedented anatomical details of tissue and structural characteristics from digitally rendered 3D cardiac models.
- Helps pinpoint arrhythmogenic areas in scar tissue with accuracy and precision for VT ablation therapy.
- Simplifies and enhances the approach to VT ablation therapy, making procedures faster and simpler.
- Allows physicians to understand each patient's unique anatomy before the procedure, focusing on therapy rather than planning.
- Seamless integration into electroanatomic mapping (EAM) systems and compatible with all major EAM systems.
- Considered an amazing group of people to work with to improve patient health and outcomes.
Limitations
- Limited public reviews available on major platforms like G2, Glassdoor, and Capterra directly for inHEART as a product or employer.
- Comparison on G2 is primarily against general patient engagement and medical practice management software, not direct competitors in cardiac digital twin technology.
- No specific employer reviews found on Glassdoor or Capterra for inHEART.
- Reddit discussions about 'iHeart' or 'in heart' are largely unrelated to the medical technology company 'inHEART'.
Based on reviews from: G2, inHeart medical (Company Website), PubMed, Reddit
Last updated: 2026-07-18
Videos
News, demos, and interviews about inHEART.
Videos load interactively. If none appear, search YouTube for inHEART →
Press & Coverage
Frequently Asked Questions
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]